Nolan Vincent Chalifoux
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Nolan Vincent Chalifoux has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
Darko Stefanovski
Department of Clinical Studies New Bolton Center, School of Veterinary Medicine University of Pennsylvania Philadelphia Pennsylvania USA
3 shared publications- Deborah C. Silverstein
Department of Clinical Sciences and Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA
3 shared publications Yu Ueda
Department of Clinical Sciences, College of Veterinary Medicine North Carolina State University Raleigh North Carolina USA
3 shared publicationsAlessio Vigani
Clinic for Small Animal Medicine, Vetsuisse Faculty, University of Zurich , Zurich
2 shared publications- Alex Michael Lynch
Department of Clinical Sciences, College of Veterinary Medicine North Carolina State University Raleigh North Carolina USA
2 shared publications Caryn M. Ehrhardt
University of Florida, College of Veterinary Medicine Department of Small Animal Clinical Sciences Gainesville, Florida
2 shared publications
Latest Publications
- Open Access
- 1 July 2026
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 40 (4)
Successful treatment of severe iatrogenic hypercalcemia and acute kidney injury with hemodialysis in a cat
A 4-year-old male castrated domestic shorthair cat was diagnosed with a urethral obstruction after presenting for vomiting, inappetence, and inappropriate urination. The cat developed iatrogenic hypercalcemia (ionized calcium > 4 mmol/L, total calcium 57 mg/dL) and an acute kidney injury (creatinine 9.81 mg/dL) suspected to be a consequence of an overdose of calcium gluconate. Approximately 12 h after admission, the cat became comatose and developed cardiovascular instability. A 6-h hemodialysis treatment was performed using continuous venovenous hemodiafiltration on the Prismaflex platform and hypercalcemia resolved during treatment. The cat’s creatinine normalized (1.01 mg/dL) within 72 h and the cat was discharged after 6 days of hospitalization. The cat subsequently developed signs of upper respiratory and gastrointestinal disease. Diagnostics including upper gastrointestinal endoscopy and bronchoscopy showed evidence of diffuse calcification of the trachea and gastric mucosa. This case demonstrates the successful application of hemodialysis in veterinary medicine to treat an acute kidney injury and iatrogenic hypercalcemia and provides unique documentation of its potential long-term sequelae.
- 1 July 2026
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 40 (4)
Open AccessSuccessful treatment of severe iatrogenic hypercalcemia and acute kidney injury with hemodialysis in a cat
A 4-year-old male castrated domestic shorthair cat was diagnosed with a urethral obstruction after presenting for vomiting, inappetence, and inappropriate urination. The cat developed iatrogenic hypercalcemia (ionized calcium > 4 mmol/L, total calcium 57 mg/dL) and an acute kidney injury (creatinine 9.81 mg/dL) suspected to be a consequence of an overdose of calcium gluconate. Approximately 12 h after admission, the cat became comatose and developed cardiovascular instability. A 6-h hemodialysis treatment was performed using continuous venovenous hemodiafiltration on the Prismaflex platform and hypercalcemia resolved during treatment. The cat’s creatinine normalized (1.01 mg/dL) within 72 h and the cat was discharged after 6 days of hospitalization. The cat subsequently developed signs of upper respiratory and gastrointestinal disease. Diagnostics including upper gastrointestinal endoscopy and bronchoscopy showed evidence of diffuse calcification of the trachea and gastric mucosa. This case demonstrates the successful application of hemodialysis in veterinary medicine to treat an acute kidney injury and iatrogenic hypercalcemia and provides unique documentation of its potential long-term sequelae.
- 10 February 2026
- Published by Wiley in Journal of Veterinary Emergency and Critical Care
- Vol. 36 (2) , 211-219
Multicenter Retrospective Cohort Study Evaluating the Efficacy of Extracorporeal Therapies Versus Medical Therapy for the Treatment of Severe Baclofen Intoxication in Dogs
Objective: To compare the outcome of treatment with extracorporeal therapy (ECT) and medical therapy (MED) in dogs with baclofen intoxication. Design: Multicenter retrospective study between June 1, 2013, and October 31, 2023. Setting: Six university teaching hospitals and three private specialty hospitals. Animals: Eighty dogs treated for baclofen intoxication. Interventions: None. Measurements and Main Results: Twenty‐nine of 80 (36%) dogs required endotracheal intubation, and 18 (23%) required mechanical ventilation (MV). Twenty‐one (26%) dogs were treated with ECT, and 59 (74%) dogs received MED. The median estimated maximal exposure dose was 8.3 mg/kg (range: 3.6–48 mg/kg) in the ECT group and 5.7 mg/kg (range: 0.46–132 mg/kg) in the MED group ( p = 0.044). Nine of 21 (43%) dogs treated with ECT had an improvement in their level of consciousness. The mean duration of MV was 20 ± 11 h in dogs treated with ECT and 23 ± 23 h in dogs treated with MED. The median hospitalization time was 58 h (range: 17–124 h) in the ECT group and 24 h (range: 0.5–188 h) in the MED group. Survival was 95% for dogs treated with ECT and 92% for dogs treated with MED. Multivariable Poisson regression modeling was performed, controlling for estimated maximal exposure dose (mg/kg). ECT was associated with a shorter duration of MV (incidence rate ratio [IRR]: 0.76 [95% CI: 0.58–0.99]; p = 0.038). However, ECT was associated with longer hospitalization times (IRR: 1.57 [95% CI: 1.45–1.71]; p < 0.001). No association was found between the use of ECT and survival (odds ratio: 1.61 [95% CI: 0.16–16.13]; p = 0.684). Conclusions: ECT is associated with high survival despite large estimated exposure doses. Although ECT was associated with a shorter duration of MV, no difference was found in survival or hospitalization time.
- 10 February 2026
- Published by Wiley in Journal of Veterinary Emergency and Critical Care
- Vol. 36 (2) , 211-219
Multicenter Retrospective Cohort Study Evaluating the Efficacy of Extracorporeal Therapies Versus Medical Therapy for the Treatment of Severe Baclofen Intoxication in Dogs
Objective: To compare the outcome of treatment with extracorporeal therapy (ECT) and medical therapy (MED) in dogs with baclofen intoxication. Design: Multicenter retrospective study between June 1, 2013, and October 31, 2023. Setting: Six university teaching hospitals and three private specialty hospitals. Animals: Eighty dogs treated for baclofen intoxication. Interventions: None. Measurements and Main Results: Twenty‐nine of 80 (36%) dogs required endotracheal intubation, and 18 (23%) required mechanical ventilation (MV). Twenty‐one (26%) dogs were treated with ECT, and 59 (74%) dogs received MED. The median estimated maximal exposure dose was 8.3 mg/kg (range: 3.6–48 mg/kg) in the ECT group and 5.7 mg/kg (range: 0.46–132 mg/kg) in the MED group ( p = 0.044). Nine of 21 (43%) dogs treated with ECT had an improvement in their level of consciousness. The mean duration of MV was 20 ± 11 h in dogs treated with ECT and 23 ± 23 h in dogs treated with MED. The median hospitalization time was 58 h (range: 17–124 h) in the ECT group and 24 h (range: 0.5–188 h) in the MED group. Survival was 95% for dogs treated with ECT and 92% for dogs treated with MED. Multivariable Poisson regression modeling was performed, controlling for estimated maximal exposure dose (mg/kg). ECT was associated with a shorter duration of MV (incidence rate ratio [IRR]: 0.76 [95% CI: 0.58–0.99]; p = 0.038). However, ECT was associated with longer hospitalization times (IRR: 1.57 [95% CI: 1.45–1.71]; p < 0.001). No association was found between the use of ECT and survival (odds ratio: 1.61 [95% CI: 0.16–16.13]; p = 0.684). Conclusions: ECT is associated with high survival despite large estimated exposure doses. Although ECT was associated with a shorter duration of MV, no difference was found in survival or hospitalization time.
- Open Access
- 29 May 2024
- Published by Springer Nature in Neurocritical Care
- Vol. 41 (3) , 1055-1072
Cerebral Autoregulation: A Target for Improving Neurological Outcomes in Extracorporeal Life Support
Despite improvements in survival after illnesses requiring extracorporeal life support, cerebral injury continues to hinder successful outcomes. Cerebral autoregulation (CA) is an innate protective mechanism that maintains constant cerebral blood flow in the face of varying systemic blood pressure. However, it is impaired in certain disease states and, potentially, following initiation of extracorporeal circulatory support. In this review, we first discuss patient-related factors pertaining to venovenous and venoarterial extracorporeal membrane oxygenation (ECMO) and their potential role in CA impairment. Next, we examine factors intrinsic to ECMO that may affect CA, such as cannulation, changes in pulsatility, the inflammatory and adaptive immune response, intracranial hemorrhage, and ischemic stroke, in addition to ECMO management factors, such as oxygenation, ventilation, flow rates, and blood pressure management. We highlight potential mechanisms that lead to disruption of CA in both pediatric and adult populations, the challenges of measuring CA in these patients, and potential associations with neurological outcome. Altogether, we discuss individualized CA monitoring as a potential target for improving neurological outcomes in extracorporeal life support.
- 29 May 2024
- Published by Springer Nature in Neurocritical Care
- Vol. 41 (3) , 1055-1072
Open AccessCerebral Autoregulation: A Target for Improving Neurological Outcomes in Extracorporeal Life Support
Despite improvements in survival after illnesses requiring extracorporeal life support, cerebral injury continues to hinder successful outcomes. Cerebral autoregulation (CA) is an innate protective mechanism that maintains constant cerebral blood flow in the face of varying systemic blood pressure. However, it is impaired in certain disease states and, potentially, following initiation of extracorporeal circulatory support. In this review, we first discuss patient-related factors pertaining to venovenous and venoarterial extracorporeal membrane oxygenation (ECMO) and their potential role in CA impairment. Next, we examine factors intrinsic to ECMO that may affect CA, such as cannulation, changes in pulsatility, the inflammatory and adaptive immune response, intracranial hemorrhage, and ischemic stroke, in addition to ECMO management factors, such as oxygenation, ventilation, flow rates, and blood pressure management. We highlight potential mechanisms that lead to disruption of CA in both pediatric and adult populations, the challenges of measuring CA in these patients, and potential associations with neurological outcome. Altogether, we discuss individualized CA monitoring as a potential target for improving neurological outcomes in extracorporeal life support.
- 1 June 2023
- Published by Wiley in Veterinary Clinical Pathology
- Vol. 52 (2) , 217-227
Comparison of a viscoelastic point-of-care coagulation monitor with thromboelastography in sick dogs with hemostatic abnormalities
BackgroundViscoelastic coagulation monitor (VCM-Vet) is a point-of-care device that has been used to characterize hemostatic abnormalities in sick pets but has not been validated in veterinary patients. ObjectivesWe aimed to compare VCM-Vet and thromboelastography (TEG) in sick dogs with suspected disorders of hemostasis. MethodsDuplicate VCM-Vet tests using untreated native blood performed concurrently on two VCM-Vet machines, and simultaneous TEG tests were performed (one citrated native (CN), and one activated with tissue factor (TF) at a 1:3600 dilution). Each VCM-Vet result was compared with both TF-activated and CN TEG. ResultsFifty-three dogs were enrolled. Eleven cases displayed apparent hyperfibrinolysis. Spearman correlation coefficients for individual VCM-Vet devices and CN and TF TEG were obtained between R and CT values and ranged from 0.21 to 0.27, CFT and K (r = 0.60-0.67), angles (r = 0.51-0.62), and MCF and MA (r = 0.85-0.87). Comparison of the two VCM-Vet devices displayed positive correlations for all clot formation parameters with Lin's concordance correlation coefficients of 0.75-0.95. Variable lysis parameter agreement existed between the VCM-Vet devices and VCM-Vet and TEG. When samples were classified as hypercoagulable or coagulopathic, VCM-Vet had a low positive predictive value (17-33%) for the detection of hypercoagulable states and a moderate negative predictive value (64-74%) for the detection of coagulopathy as defined by TEG. ConclusionsVCM-Vet and TEG had variable correlations in clot formation values and a strong correlation for final clot strength. More information is needed to make conclusions about the lysis parameters. Artifact in the fibrinolysis portion of the test can confound the interpretation of VCM-Vet results.
- 1 June 2023
- Published by Wiley in Veterinary Clinical Pathology
- Vol. 52 (2) , 217-227
Comparison of a viscoelastic point-of-care coagulation monitor with thromboelastography in sick dogs with hemostatic abnormalities
BackgroundViscoelastic coagulation monitor (VCM-Vet) is a point-of-care device that has been used to characterize hemostatic abnormalities in sick pets but has not been validated in veterinary patients. ObjectivesWe aimed to compare VCM-Vet and thromboelastography (TEG) in sick dogs with suspected disorders of hemostasis. MethodsDuplicate VCM-Vet tests using untreated native blood performed concurrently on two VCM-Vet machines, and simultaneous TEG tests were performed (one citrated native (CN), and one activated with tissue factor (TF) at a 1:3600 dilution). Each VCM-Vet result was compared with both TF-activated and CN TEG. ResultsFifty-three dogs were enrolled. Eleven cases displayed apparent hyperfibrinolysis. Spearman correlation coefficients for individual VCM-Vet devices and CN and TF TEG were obtained between R and CT values and ranged from 0.21 to 0.27, CFT and K (r = 0.60-0.67), angles (r = 0.51-0.62), and MCF and MA (r = 0.85-0.87). Comparison of the two VCM-Vet devices displayed positive correlations for all clot formation parameters with Lin's concordance correlation coefficients of 0.75-0.95. Variable lysis parameter agreement existed between the VCM-Vet devices and VCM-Vet and TEG. When samples were classified as hypercoagulable or coagulopathic, VCM-Vet had a low positive predictive value (17-33%) for the detection of hypercoagulable states and a moderate negative predictive value (64-74%) for the detection of coagulopathy as defined by TEG. ConclusionsVCM-Vet and TEG had variable correlations in clot formation values and a strong correlation for final clot strength. More information is needed to make conclusions about the lysis parameters. Artifact in the fibrinolysis portion of the test can confound the interpretation of VCM-Vet results.
- Open Access
- 1 January 2023
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 37 (1) , 161-172
Outcomes of 434 dogs with non-steroidal anti-inflammatory drug toxicosis treated with fluid therapy, lipid emulsion, or therapeutic plasma exchange
Background: Traditional management of non-steroidal anti-inflammatory drug (NSAID) intoxication includes gastrointestinal decontamination, intravenous administration of fluids (IVF), and gastroprotection. Intravenous administration of lipid emulsion (ILE) and therapeutic plasma exchange (TPE) are popular novel therapeutic strategies. Hypothesis: Compare outcomes of dogs treated with IVF, ILE, and TPE for NSAID intoxications and evaluate outcome predictors for drug subgroups. Animals: Four hundred thirty-four dogs with NSAID intoxications (2015-2020). Methods: Multicenter retrospective study of ibuprofen, carprofen, and naproxen intoxication. An ordinal outcome was defined as mild gastrointestinal, moderate kidney, or signs of severe central nervous system disease. Results: Signs of neurological disease were overrepresented and acute kidney injury underrepresented in the TPE group among dogs exposed to kidney- or CNS-toxic doses (P = .05), though all TPE dogs with signs of neurological disease had evidence of neurotoxicity at presentation. Dogs treated with IVF had a higher maximal creatinine concentration (median, 1.1 mg/dL; range, 0.4-8.44 mg/dL) compared with IVF + ILE (median, 0.9 mg/dL; range, 0.4-6.2 mg/dL; P = .01). Increased maximum time to presentation (P < .001), higher baseline creatinine (P < .001) and PCV (P = .007), and absence of induced emesis (P < .001) were associated with greater clinical severity. Ibuprofen toxicosis was associated with more severe clinical signs compared with carprofen (P = .03). Overall survival rate was 99%. Conclusions and Clinical Importance: NSAID toxicosis generally carries an excellent prognosis in dogs. Despite similar outcomes of lower incidence of AKI in the TPE group, and slightly lower maximal creatinine concentration in dogs treated with ILE vs IVF alone, ILE and TPE should be considered in the management of severe NSAID toxicosis.
- 1 January 2023
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 37 (1) , 161-172
Open AccessOutcomes of 434 dogs with non-steroidal anti-inflammatory drug toxicosis treated with fluid therapy, lipid emulsion, or therapeutic plasma exchange
Background: Traditional management of non-steroidal anti-inflammatory drug (NSAID) intoxication includes gastrointestinal decontamination, intravenous administration of fluids (IVF), and gastroprotection. Intravenous administration of lipid emulsion (ILE) and therapeutic plasma exchange (TPE) are popular novel therapeutic strategies. Hypothesis: Compare outcomes of dogs treated with IVF, ILE, and TPE for NSAID intoxications and evaluate outcome predictors for drug subgroups. Animals: Four hundred thirty-four dogs with NSAID intoxications (2015-2020). Methods: Multicenter retrospective study of ibuprofen, carprofen, and naproxen intoxication. An ordinal outcome was defined as mild gastrointestinal, moderate kidney, or signs of severe central nervous system disease. Results: Signs of neurological disease were overrepresented and acute kidney injury underrepresented in the TPE group among dogs exposed to kidney- or CNS-toxic doses (P = .05), though all TPE dogs with signs of neurological disease had evidence of neurotoxicity at presentation. Dogs treated with IVF had a higher maximal creatinine concentration (median, 1.1 mg/dL; range, 0.4-8.44 mg/dL) compared with IVF + ILE (median, 0.9 mg/dL; range, 0.4-6.2 mg/dL; P = .01). Increased maximum time to presentation (P < .001), higher baseline creatinine (P < .001) and PCV (P = .007), and absence of induced emesis (P < .001) were associated with greater clinical severity. Ibuprofen toxicosis was associated with more severe clinical signs compared with carprofen (P = .03). Overall survival rate was 99%. Conclusions and Clinical Importance: NSAID toxicosis generally carries an excellent prognosis in dogs. Despite similar outcomes of lower incidence of AKI in the TPE group, and slightly lower maximal creatinine concentration in dogs treated with ILE vs IVF alone, ILE and TPE should be considered in the management of severe NSAID toxicosis.
- Open Access
- 5 August 2022
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 36 (5) , 1641-1647
Outcomes of nonsteroidal anti-inflammatory drug toxicosis treated with therapeutic plasma exchange in 62 dogs
Background: Therapeutic plasma exchange (TPE) is gaining popularity for the management of nonsteroidal anti-inflammatory drug (NSAID) overdose in dogs. Hypothesis/Objectives: Describe a population of dogs treated with TPE for NSAID overdose. Animals: Sixty-two dogs with NSAID overdose treated with TPE. Methods: Multicenter retrospective study of dogs treated with TPE for ibuprofen, carprofen, or naproxen overdose. Results: The median dose of ibuprofen, carprofen or naproxen ingested was 533 mg/kg (range, 36-4857 mg/kg), 217 mg/kg (range, 88-625 mg/kg) and 138 mg/kg (range, 26-3000 mg/kg), respectively. Based on previously established toxic ranges for each NSAID, 2 (3.2%), 14 (22.6%), and 46 (74.2%) dogs ingested a gastrointestinal, renal, and neurological toxic dose, respectively. The median time between ingestion and presentation was 4 hours (range, 1-20 hours). The median number of plasma volumes processed was 1.6 (range, 0.4-2.2). The median TPE session duration was 2 hours (range, 1-4.5 hours). Circuit clotting developed during 8 (12.9%) sessions. Patient adverse events reported during 21 (33.8%) sessions consisted of urticaria (12.9%), asymptomatic hypocalcemia (9.6%), and hypotension (9.6%). The median duration of hospitalization was 2.25 days (range, 1-11 days). Sixty-one (98.4%) dogs survived to discharge, and none were rehospitalized. Thirty-one (91.1%) of the 34 dogs with at least 1 follow-up visit were not azotemic at the time of reevaluation. Conclusions and Clinical Importance: This population of dogs managed with TPE had excellent outcomes, even in cases of high NSAID dose ingestion. When TPE is available and the time frame is appropriate, this extracorporeal modality should be considered for the management of NSAID overdose.
- 5 August 2022
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 36 (5) , 1641-1647
Open AccessOutcomes of nonsteroidal anti-inflammatory drug toxicosis treated with therapeutic plasma exchange in 62 dogs
Background: Therapeutic plasma exchange (TPE) is gaining popularity for the management of nonsteroidal anti-inflammatory drug (NSAID) overdose in dogs. Hypothesis/Objectives: Describe a population of dogs treated with TPE for NSAID overdose. Animals: Sixty-two dogs with NSAID overdose treated with TPE. Methods: Multicenter retrospective study of dogs treated with TPE for ibuprofen, carprofen, or naproxen overdose. Results: The median dose of ibuprofen, carprofen or naproxen ingested was 533 mg/kg (range, 36-4857 mg/kg), 217 mg/kg (range, 88-625 mg/kg) and 138 mg/kg (range, 26-3000 mg/kg), respectively. Based on previously established toxic ranges for each NSAID, 2 (3.2%), 14 (22.6%), and 46 (74.2%) dogs ingested a gastrointestinal, renal, and neurological toxic dose, respectively. The median time between ingestion and presentation was 4 hours (range, 1-20 hours). The median number of plasma volumes processed was 1.6 (range, 0.4-2.2). The median TPE session duration was 2 hours (range, 1-4.5 hours). Circuit clotting developed during 8 (12.9%) sessions. Patient adverse events reported during 21 (33.8%) sessions consisted of urticaria (12.9%), asymptomatic hypocalcemia (9.6%), and hypotension (9.6%). The median duration of hospitalization was 2.25 days (range, 1-11 days). Sixty-one (98.4%) dogs survived to discharge, and none were rehospitalized. Thirty-one (91.1%) of the 34 dogs with at least 1 follow-up visit were not azotemic at the time of reevaluation. Conclusions and Clinical Importance: This population of dogs managed with TPE had excellent outcomes, even in cases of high NSAID dose ingestion. When TPE is available and the time frame is appropriate, this extracorporeal modality should be considered for the management of NSAID overdose.
- 21 June 2022
- Published by Wiley in Veterinary Clinical Pathology
- Vol. 51 (4) , 533-542
Clinical application of the StatSensor and StatSensor Xpress point‐of‐care creatinine measurement devices in dogs
Background Creatinine is a universally important blood parameter used to detect and monitor acute and chronic kidney disease. Reliable measurements at the bedside remain a challenge in human and veterinary medicine. Despite its potential, a trustworthy point-of-care creatinine biosensor has yet to be established. Objectives We aimed to determine the precision and accuracy of the StatSensor (SS) and StatSensor Xpress (SSX) handheld creatinine measurement devices in dogs. Methods Paired creatinine samples from dogs with normal (creatinine <= 159 mu mol/L), moderate (159-354 mu mol/L), and marked (>354 mu mol/L) azotemia were compared with a commercial enzymatic analyzer. Within-day precision and linearity studies were performed prior to method comparison studies. Method comparison was evaluated using Bland-Altman, concordance correlation coefficient, Deming, and Passing-Bablok regression analysis. Results Seventy-eight dogs were enrolled in the study, including 28 (35%), 25 (32%), and 26 (33%) with normal, moderate, and marked azotemia. Total error surpassed recommendations for all devices, and linearity deviated from identity for the SS1 and SS2. The concordance correlation coefficients of the SS1, SS2, SSXI, and SSX2, were 0.69, 0.59, 0.82, and 0.44, respectively. Bland-Altman analyses showed a high variation in the differences, and relationships showed high heteroskedasticity with negative systemic bias among high creatinine concentrations. Conclusions Neither the SS and SSX are considered acceptable for clinical applications in dogs. Further research is indicated for the development of a reliable, cost-effective, point-of-care creatinine analyzer to improve the rapid detection and monitoring human and veterinary patients.
- 21 June 2022
- Published by Wiley in Veterinary Clinical Pathology
- Vol. 51 (4) , 533-542
Clinical application of the StatSensor and StatSensor Xpress point‐of‐care creatinine measurement devices in dogs
Background Creatinine is a universally important blood parameter used to detect and monitor acute and chronic kidney disease. Reliable measurements at the bedside remain a challenge in human and veterinary medicine. Despite its potential, a trustworthy point-of-care creatinine biosensor has yet to be established. Objectives We aimed to determine the precision and accuracy of the StatSensor (SS) and StatSensor Xpress (SSX) handheld creatinine measurement devices in dogs. Methods Paired creatinine samples from dogs with normal (creatinine <= 159 mu mol/L), moderate (159-354 mu mol/L), and marked (>354 mu mol/L) azotemia were compared with a commercial enzymatic analyzer. Within-day precision and linearity studies were performed prior to method comparison studies. Method comparison was evaluated using Bland-Altman, concordance correlation coefficient, Deming, and Passing-Bablok regression analysis. Results Seventy-eight dogs were enrolled in the study, including 28 (35%), 25 (32%), and 26 (33%) with normal, moderate, and marked azotemia. Total error surpassed recommendations for all devices, and linearity deviated from identity for the SS1 and SS2. The concordance correlation coefficients of the SS1, SS2, SSXI, and SSX2, were 0.69, 0.59, 0.82, and 0.44, respectively. Bland-Altman analyses showed a high variation in the differences, and relationships showed high heteroskedasticity with negative systemic bias among high creatinine concentrations. Conclusions Neither the SS and SSX are considered acceptable for clinical applications in dogs. Further research is indicated for the development of a reliable, cost-effective, point-of-care creatinine analyzer to improve the rapid detection and monitoring human and veterinary patients.
- 28 June 2021
- Published by Wiley in Journal of Veterinary Emergency and Critical Care
- Vol. 31 (5) , 585-594
Standardized capillary refill time and relation to clinical parameters in hospitalized dogs
Objective To assess the relationship between various physical and clinicopathologic parameters and the capillary refill time (CRT) using a standard method; to evaluate the influence of emergency room (ER) versus ICU hospital location on CRT; and to identify latent subgroups among the CRT distribution. Design Prospective, observational study. Setting University teaching hospital. Animals Client-owned dogs in the ER (n = 40) and ICU (n = 71). Interventions The CRT was defined as the duration required for the oral mucosa of the upper lip to return to its original color after blanching for 4 seconds. The CRT was recorded in seconds to the 10ths place by a single observer using an automated recording device. Measurements and Main Results Median CRT for all dogs was 1.1 seconds (ER, 1.2 s; ICU, 1.1 s; P = 1.000). The CRT was significantly associated with rectal temperature (P = 0.004), systolic blood pressure (P = 0.028), body weight (P = 0.031), mucous membrane color (P = 0.007), skin turgor (P = 0.039), and acute patient physiologic and laboratory evaluation mentation score (P = 0.019) for all dogs. The CRT was related to a greater number of variables in the ER than in the ICU patient population. In general, the total population of dogs had CRTs belonging to 1 of 2 groups: either ≤1.2 or ≥1.7 seconds. A statistically significant association was found between body weight CRT ≥1.3 seconds (P = 0.02). Conclusions A CRT following blanching for 4 seconds may provide insight into the hydration status and hemodynamic stability of canine patients. Further research into its clinical application is warranted.
- 28 June 2021
- Published by Wiley in Journal of Veterinary Emergency and Critical Care
- Vol. 31 (5) , 585-594
Standardized capillary refill time and relation to clinical parameters in hospitalized dogs
Objective To assess the relationship between various physical and clinicopathologic parameters and the capillary refill time (CRT) using a standard method; to evaluate the influence of emergency room (ER) versus ICU hospital location on CRT; and to identify latent subgroups among the CRT distribution. Design Prospective, observational study. Setting University teaching hospital. Animals Client-owned dogs in the ER (n = 40) and ICU (n = 71). Interventions The CRT was defined as the duration required for the oral mucosa of the upper lip to return to its original color after blanching for 4 seconds. The CRT was recorded in seconds to the 10ths place by a single observer using an automated recording device. Measurements and Main Results Median CRT for all dogs was 1.1 seconds (ER, 1.2 s; ICU, 1.1 s; P = 1.000). The CRT was significantly associated with rectal temperature (P = 0.004), systolic blood pressure (P = 0.028), body weight (P = 0.031), mucous membrane color (P = 0.007), skin turgor (P = 0.039), and acute patient physiologic and laboratory evaluation mentation score (P = 0.019) for all dogs. The CRT was related to a greater number of variables in the ER than in the ICU patient population. In general, the total population of dogs had CRTs belonging to 1 of 2 groups: either ≤1.2 or ≥1.7 seconds. A statistically significant association was found between body weight CRT ≥1.3 seconds (P = 0.02). Conclusions A CRT following blanching for 4 seconds may provide insight into the hydration status and hemodynamic stability of canine patients. Further research into its clinical application is warranted.
- 20 May 2021
- Published by Wiley in Journal of Veterinary Emergency and Critical Care
- Vol. 31 (4) , 508-515
Effectiveness of intravenous fluid resuscitation in hypotensive cats: 82 cases (2012–2019)
Objective To evaluate the effectiveness of intravenous fluid resuscitation in hypotensive cats in an emergency room setting. Secondary objectives were to investigate changes in heart rate (HR) and body temperature (BT) in response to fluid resuscitation, and the association of these changes with patient survival. Design Retrospective study. Setting University teaching hospital. Animals Eighty-two cats with confirmed hypotension. Interventions None. Measurements and main results Medical records from 2012 to 2019 were searched for cats that had documented systemic arterial hypotension (blood pressure measured using a Doppler ultrasonic flow probe [DBP] < 90 mm Hg) on presentation to the emergency room. Data collected included patient characteristics and DBP, HR, and BT before and after fluid resuscitation, type and volume of fluids administered, and outcome. The median DBP before and after resuscitative fluid therapy in all cats was 65 mm Hg (range, 20–85 mm Hg) and 80 mm Hg (range, 20–128 mm Hg), respectively (P < 0.001). However, only 30 cats (37%) were classified as responders to fluid resuscitation (DBP ≥ 90 mm Hg following bolus therapy). The mean HR and median BT before resuscitative fluid therapy was 159/min and 36.7°C. Following fluid resuscitation, where measured, the mean HR and median BT was 154/min (P = 1.00) and 35.9°C (P = 1.00). No significant differences in HR and BT were identified between responders and non-responders. Cats had a low survival rate of 7%. All survivors (n = 5) were initially bradycardic (HR < 160/min), compared to only 45% of non-survivors (P = 0.4). Conclusions Bolus fluid resuscitation effectively increases blood pressure in hypotensive cats; however, it does not result in normalization of blood pressure, HR, or BT in the majority of cases.
- 20 May 2021
- Published by Wiley in Journal of Veterinary Emergency and Critical Care
- Vol. 31 (4) , 508-515
Effectiveness of intravenous fluid resuscitation in hypotensive cats: 82 cases (2012–2019)
Objective To evaluate the effectiveness of intravenous fluid resuscitation in hypotensive cats in an emergency room setting. Secondary objectives were to investigate changes in heart rate (HR) and body temperature (BT) in response to fluid resuscitation, and the association of these changes with patient survival. Design Retrospective study. Setting University teaching hospital. Animals Eighty-two cats with confirmed hypotension. Interventions None. Measurements and main results Medical records from 2012 to 2019 were searched for cats that had documented systemic arterial hypotension (blood pressure measured using a Doppler ultrasonic flow probe [DBP] < 90 mm Hg) on presentation to the emergency room. Data collected included patient characteristics and DBP, HR, and BT before and after fluid resuscitation, type and volume of fluids administered, and outcome. The median DBP before and after resuscitative fluid therapy in all cats was 65 mm Hg (range, 20–85 mm Hg) and 80 mm Hg (range, 20–128 mm Hg), respectively (P < 0.001). However, only 30 cats (37%) were classified as responders to fluid resuscitation (DBP ≥ 90 mm Hg following bolus therapy). The mean HR and median BT before resuscitative fluid therapy was 159/min and 36.7°C. Following fluid resuscitation, where measured, the mean HR and median BT was 154/min (P = 1.00) and 35.9°C (P = 1.00). No significant differences in HR and BT were identified between responders and non-responders. Cats had a low survival rate of 7%. All survivors (n = 5) were initially bradycardic (HR < 160/min), compared to only 45% of non-survivors (P = 0.4). Conclusions Bolus fluid resuscitation effectively increases blood pressure in hypotensive cats; however, it does not result in normalization of blood pressure, HR, or BT in the majority of cases.
- 31 March 2021
- Published by Wiley in Journal of Veterinary Emergency and Critical Care
- Vol. 31 (3) , 402-413
Prognostic indicators at presentation for canine parvoviral enteritis: 322 cases (2001‐2018)
Objective: To evaluate clinicopathological prognostic indicators associated with survival based on hematology and serum biochemistry profile findings at presentation of dogs with canine parvoviral enteritis (CPE). Secondary objectives were to describe the signalment, history, physical examination findings, and progression of disease while in hospital and correlate them to survival.Design: Retrospective study from medical records of dogs diagnosed with CPE between 2001 and 2018.Setting: University teaching hospital.Animals: Three hundred twenty‐two dogs diagnosed with CPE that received in‐hospital treatment.Interventions: None.Measurements and main results: Of 322 hospitalized dogs, 294 dogs (91%) survived infection with a median hospitalization time of 79 hours. Multivariable analysis showed that glucose (P = 0.04), total magnesium (P = 0.011), and the dichotomized variable of a low HCT (P = 0.033) on presentation were significantly associated with survival. For every 1 mmol/L (18 mg/dL) decrease in glucose concentration, cases had 1.85 lower odds of survival. For every 0.1 mmol/L (0.2 mEq/L) increase in total magnesium concentration, cases had 2.50 lower odds of survival. Cases with a low HCT had 10.69 lower odds of survival. On univariable analyses, non‐survivors had a lower median body weight (P = 0.006) and presented more commonly for diarrhea (P = 0.015). At least 1 episode of diarrhea (P = 0.003) and hematochezia or melena (P < 0.001) in hospital were negatively associated with outcome, in addition to the persistence of diarrhea (P = 0.026) and hyporexia (P = 0.018) in hospital for 5 to 6 days.Conclusions: Survival rates of 91% were achieved with in‐hospital treatment in this cohort of dogs. Negative biochemical prognostic indicators affecting survival include a low HCT, decreased blood glucose concentrations, and increased total serum magnesium concentrations at presentation.
- 31 March 2021
- Published by Wiley in Journal of Veterinary Emergency and Critical Care
- Vol. 31 (3) , 402-413
Prognostic indicators at presentation for canine parvoviral enteritis: 322 cases (2001‐2018)
Objective: To evaluate clinicopathological prognostic indicators associated with survival based on hematology and serum biochemistry profile findings at presentation of dogs with canine parvoviral enteritis (CPE). Secondary objectives were to describe the signalment, history, physical examination findings, and progression of disease while in hospital and correlate them to survival.Design: Retrospective study from medical records of dogs diagnosed with CPE between 2001 and 2018.Setting: University teaching hospital.Animals: Three hundred twenty‐two dogs diagnosed with CPE that received in‐hospital treatment.Interventions: None.Measurements and main results: Of 322 hospitalized dogs, 294 dogs (91%) survived infection with a median hospitalization time of 79 hours. Multivariable analysis showed that glucose (P = 0.04), total magnesium (P = 0.011), and the dichotomized variable of a low HCT (P = 0.033) on presentation were significantly associated with survival. For every 1 mmol/L (18 mg/dL) decrease in glucose concentration, cases had 1.85 lower odds of survival. For every 0.1 mmol/L (0.2 mEq/L) increase in total magnesium concentration, cases had 2.50 lower odds of survival. Cases with a low HCT had 10.69 lower odds of survival. On univariable analyses, non‐survivors had a lower median body weight (P = 0.006) and presented more commonly for diarrhea (P = 0.015). At least 1 episode of diarrhea (P = 0.003) and hematochezia or melena (P < 0.001) in hospital were negatively associated with outcome, in addition to the persistence of diarrhea (P = 0.026) and hyporexia (P = 0.018) in hospital for 5 to 6 days.Conclusions: Survival rates of 91% were achieved with in‐hospital treatment in this cohort of dogs. Negative biochemical prognostic indicators affecting survival include a low HCT, decreased blood glucose concentrations, and increased total serum magnesium concentrations at presentation.